Listed on BSE under the Financial Services classification, Relic Technologies Limited is currently a holding-company structure with two subsidiaries — Relic Pharma Limited and Truhealthy Wellness Private Limited — operating in the pharma and wellness space. On a standalone basis, revenue from operations is nil: filings state the planned shift to pharma and wellness products has not yet started because the company is waiting for regulatory permissions. The operational activity sits in the consolidated books, where revenue from operations reached Rs. 220.07 lakhs in the first nine months of FY26, up about 46% year-on-year. The two subsidiaries together posted a pre-tax loss of Rs. 414.32 lakhs in 9M FY26, and the standalone entity swung to a full-year FY26 net loss of Rs. 694.49 lakhs against a profit of Rs. 54.20 lakhs in FY25, partly due to exceptional items of Rs. 232.12 lakhs. To fund the build-out, the company raised Rs. 1,692.48 lakhs via a preferential issue (equity plus convertible warrants) in FY26, of which Rs. 558 lakhs had been cumulatively utilised by March 2026 for working capital, investments, acquisitions and general corporate purposes. A related-party proposal seeks shareholder approval for transactions with Truhealthy Wellness of up to Rs. 10 crore in purchases/sales and Rs. 25 crore in loans. Employee cost is the dominant expense at 160.7% of standalone revenue, reflecting staff being on board while revenue-generating activity is still pending. AR · MarketPing reader · 2026-08-02
Revenue streams, as the annual report describes them. Pharma (via subsidiary Relic Pharma Limited), Wellness (via subsidiary Truhealthy Wellness Private Limited), Standalone operations. Loss-making, transition-stage holding company pivoting from a financial-services classification into pharma and wellness.
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 2 | 1 | 2 | 2 | 3 |
| EBITDA (ex other income) | 1 | 0 | (1) | (1) | (7) |
| margin % | 31.9 | 24.1 | (51.9) | (59.3) | (270.7) |
| Owners' profit | 0 | 0 | (1) | (1) | (5) |
| EPS, as reported (₹) | 1.39 | 0.53 | (2.42) | 4.13 | 13.19 |
| ROE % · ROCE % | 7.5 · 9.8 | 3.8 · 5.6 | (17.6) · (15.9) | (17.0) · (14.5) | (55.5) · (51.4) |
| Debt / equity (x) | 0.00 | 0.00 | 0.07 | 0.17 | 0.12 |
| Cash from operations | 0 | 0 | 0 | (0) | (17) |
| Capex | (0) | (0) | (1) | (0) | (0) |
| ₹ crore | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 |
| Profit before tax | (0) | 0 | (1) | (1) | (4) | (1) | (2) | (1) |
| Net profit | (0) | 0 | (1) | (1) | (4) | 0 | (0) | (3) |
| EPS (₹) | (0.29) | 0.40 | (2.77) | 1.46 | 7.25 | 0.30 | 0.92 | 5.58 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| CRISIL LTD | 34,342 | 38.9 | 10.50 | — | 13.7 | 16.1 | — | 30.6 |
| ONEMI TECHNOLOGY SOL LTD | 5,526 | 19.6 | 4.12 | 9.4 | 21.0 | 18.8 | — | 32.0 |
| GYFTR LIMITED | 1,359 | — | 2.80 | 41.8 | 4.5 | 5.3 | 32.8 | 4.3 |
| CENTRUM CAPITAL LIMITED | 1,077 | — | 0.82 | 9.7 | (21.4) | (2.5) | 49.7 | 29.7 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 13 Aug 2026 · No deviation in use of preferential issue funds for Q1FY27 | compliance | minimal | — | — |
| 13 Aug 2026 · Relic Tech Q1 FY27: Standalone profit up, consolidated loss narrows | results | high | — | — |
| 13 Aug 2026 · Relic Technologies Q1 FY27 Results: Standalone Profit Up, Group Posts Loss | results | high | — | — |
| 6 Aug 2026 · Board meeting on Aug 13, 2026 to consider Q1 FY27 results | results | low | — | — |
| 27 Jul 2026 · Reg 74(5) certificate filing for quarter ended June 30, 2026 | compliance | minimal | — | — |
| 23 Jul 2026 · Newspaper Publication of 35th AGM Notice | compliance | minimal | — | — |
| 21 Jul 2026 · Relic Technologies submits 35th AGM notice and Annual Report for FY 2025-26 | board shareholder meetings | low | — | — |
| 18 Jul 2026 · Newspaper publication of 35th AGM notice by Relic Technologies | compliance | minimal | — | — |
| 27 Jun 2026 · Trading window closed for quarter ended June 2026 | compliance | minimal | — | — |
| 25 May 2026 · Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2026 | compliance | minimal | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| PRIME SECURITIES LIMITED |
| 961 |
| 171.5 |
| 3.75 |
| 87.4 |
| 5.1 |
| — |
| 25.7 |
| 19.0 |
| WEALTH FRST PORT. MG. LTD | 900 | 27.3 | 5.29 | 17.3 | 22.5 | 30.3 | — | 97.5 |
| STELLANT SECURITIES (INDIA) LT | 559 | — | 1784.58 | — | 18.2 | 18.2 | — | 56.7 |
| THE INVEST TRUST OF IND L | 511 | 15.3 | 0.70 | 7.1 | 4.7 | 3.9 | (2.4) | 23.4 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 4.8 | 17.9 | 15 of 95 | 85% |
| P/B | 3.0 | 1.2 | 81 of 101 | 20% |
| ROCE | (52.1) | 1.6 | 81 of 84 | 4% |
| ROE | (55.5) | 1.3 | 112 of 115 | 3% |
| Debt / Equity | 0.1 | 0.0 | 90 of 115 | 22% |
| EBITDA margin | (164.4) | 25.6 | 87 of 91 | 4% |
| Revenue growth | 0.5 | (4.1) | 40 of 85 | 54% |
| Profit growth | (457.7) | (0.2) | 103 of 109 | 6% |
| Market cap | 38 | 28 | 47 of 109 | 57% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
